Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 74, Issue 5, 2015, Pages 813-817

  Eder, Lihi ^a   Thavaneswaran, Arane ^a   Chandran, Vinod ^a   Cook, Richard J ^b   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT;

ADULT; ARTHRALGIA; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; ENTHESITIS; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL DISEASE ACTIVITY; OBESITY; PAIN ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; SCORING SYSTEM; SKIN DISEASE; VISUAL ANALOG SCALE; AGED; ARTHRITIS, PSORIATIC; COMORBIDITY; DOSE RESPONSE; MIDDLE AGED; OVERWEIGHT; PROSPECTIVE STUDY; REGRESSION ANALYSIS; REMISSION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROBABILITY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REMISSION INDUCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84926651853     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204448     Document Type: Article

References (33)

1. Gladman DD, Antoni C, Mease P., et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005; 64(suppl 2):ii14-17.
2. Bhole VM, Choi HK, Burns L.C., et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 2012; 51:552-6.
3. Kumar S, Han J, Li T., et al. Obesity, waist circumference, weight change and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol 2013; 27:1293-8.
4. Love TJ, Zhu Y, Zhang Y., et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012; 71:1273-7.
5. Li W, Han J, Qureshi AA Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012; 71:1267-72.
6. Armstrong AW, Harskamp CT, Armstrong EJ The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012; 2:e54.
7. Carrascosa JM, Vilavella M, Garcia-Doval I, et al. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. J Eur Acad Dermatol Venereol 2013. Epub 15 Jul 2013.
8. Zhang C, Zhu KJ, Zheng H.F., et al. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study. J Eur Acad Dermatol Venereol 2011; 25:87-91.
9. Jensen P, Zachariae C, Christensen R., et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol 2013; 149:795-801.
10. di Minno M.N., Peluso R, Iervolino S., et al. Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken). 2013; 65:141-7.
11. Di Minno M.N., Peluso R, Iervolino S., et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor alpha blockers. Ann Rheum Dis 2014; 73:1157-62.
12. Eder L, Jayakar J, Pollock R., et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis 2013; 72:1956-61.
13. Coimbra S, Oliveira H, Reis F., et al. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24:1386-94.
14. Xue Y, Jiang L, Cheng Q., et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS ONE 2012; 7: e46740.
15. Taylor W, Gladman D, Helliwell P., et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665-73.
16. Gladman DD, Shuckett R, Russell M.L., et al. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987; 62:127-41.
17. Coates LC, Cook R, Lee K.A., et al. Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res (Hoboken) 2010; 62:970-6.
18. Farias MM, Achurra P, Boza C., et al. Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients. Obes Surg 2012; 22:877-80.
19. Gotay CC, Katzmarzyk PT, Janssen I, et al Updating the Canadian obesity maps: an epidemic in progress. Can J Public Health 2013; 104:e64-8.
20. Hamminga EA, van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67:768-73.
21. Gualillo O. Mediators of inflammation in obesity and its comorbidities. Mediators Inflamm 2010. Epub 21 Sept 2010.
22. Davidovici BB, Sattar N, Prinz J., et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130:1785-96.
23. McGonagle D, Ash Z, Dickie L., et al. The early phase of psoriatic arthritis. Ann Rheum Dis 2011; 70(suppl 1):i71-6.
24. Stone AA, Broderick JE Obesity and pain are associated in the United States. Obesity (Silver Spring) 2012; 20:1491-5.
25. Wright LJ, Schur E, Noonan C., et al. Chronic pain, overweight, and obesity: findings from a community-based twin registry. J Pain 2010; 11:628-35.
26. Ajeganova S, Andersson ML, Hafstrom I. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res (Hoboken) 2013; 65:78-87.
27. Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2013; 39:1-19.
28. Radner H, Smolen JS, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011; 50:381-8.
29. Eder L, Thavaneswaran A, Chandran V., et al. The association between obesity and joint damage among patients with psoriatic arthritis. Arthritis Rheum 2013; 65(Suppl 10):339.
30. Baker JF, George M, Baker D.G., et al. Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology (Oxford) 2011; 50:2100-7.
31. van der Helm-van Mil AH, van der Kooij SM, Allaart CF, et al. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 2008; 67:769-74.
32. Hernan MA, Brumback B, Robins JM Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-70.
33. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-60.